Detailed instructions for Sotoraxibu! A must-read for patients before taking medication!

1. Indications:

Sotorasib is a drug used to treat KRAS G12C mutant non-small cell lung cancer (NSCLC). The drug is designed to provide a targeted treatment option for patients whose disease has progressed despite other treatments.

2. Mechanism of action:

Sotoracib is a KRAS G12C inhibitor that blocks abnormal signaling pathways in cancer cells by specifically interfering with KRAS G12C mutants. This stops cancer cells from growing, dividing and spreading, thus inhibiting tumor development.

3. Pharmacology:

Sotorasiib binds to the KRAS G12C protein and interferes with its active site, thereby preventing the overactivation of the RAS pathway. This precise drug action mechanism enables it to show significant efficacy in the treatment of KRAS G12C mutated NSCLC.

4. Dosage and usage:

Generally, sotorasiib is given orally to patients. The specific dosage should be determined by a professional doctor based on the patient's weight, physical condition and other factors. In clinical trials, a dose of 960 mg once daily was generally recommended.

5. Side effects:

Patients may experience some side effects when using sotoraxib, including but not limited to fatigue, nausea, vomiting, diarrhea, skin inflammation, etc. If patients experience any discomfort, they should report it to their doctor immediately.

6. Warnings and precautions:

During the use of sotoraxib, patients need to undergo regular clinical monitoring and examinations to evaluate the efficacy and possible side effects of the drug.

Pregnant and nursing women should use it under the guidance of a doctor to avoid potential fetal or infant risks.

7. Contraindications:

1.It is contraindicated in patients allergic to any component of sotoraxib.

2.Interactions with certain drugs may cause adverse reactions, so the doctor should be informed of all drugs the patient is taking before use.

8. Drug interactions:

Patients should inform their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements, while taking sotorasiib to avoid adverse drug interactions.

9. Medication for special groups:

1.For elderly patients and patients with hepatic or renal insufficiency, the dosage may need to be adjusted.

2.The safety and effectiveness of the drug in children and adolescent patients have not been determined and should be used under the supervision of a professional doctor.

10. Listing and price situation:

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.

Overall, patients should consult a professional physician before using sotorasiib, use the drug strictly in accordance with the physician's recommendations, and report any discomfort or abnormalities at any time.